Moderna

News

Moderna jab on trial for cancer-causing syndrome

Patients with Lynch syndrome could have a potential treatment on the horizon, as a Moderna mRNA vaccine starts trials at Oxford University.

News

CEPI puts $60m behind three Ebola vaccine candidates

Moderna has been awarded $50m from CEPI for a Bundibugyo ebolavirus vaccine candidate, with funding also made available to two other candidates.

News

Stéphane Bancel, Moderna's chief executive.

Moderna's Q1 revenues rocket, thanks to ex-US sales

Moderna saw its Q1 sales nearly triple to $389m, almost a threefold rise on the same period of 2025, with international markets driving the increase.

News

Pivotal trial of Moderna's H5N1 bird flu jab gets underway

The first volunteers in a large-scale trial of Moderna's mRNA-based vaccine against bird flu have received shots in the UK and US.

News

OpenAI introduces GPT-Rosalind, its drug discovery AI

In this week's second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin.

News

GSK's RSV shot cleared in US for all adults

GSK is back on level pegging with its rivals in the RSV vaccine category in the US, after getting FDA approval for Arexvy in the 18 to 49 age bracket.

Moderna jab on trial for cancer-causing syndrome

CEPI puts $60m behind three Ebola vaccine candidates

Moderna's Q1 revenues rocket, thanks to ex-US sales

Pivotal trial of Moderna's H5N1 bird flu jab gets underway

OpenAI introduces GPT-Rosalind, its drug discovery AI

GSK's RSV shot cleared in US for all adults

Bayer's asundexian starts EU review for ischaemic stroke

Discover a new era of healthcare panel engagement: Grounded ...

Moderna

Editor's Picks